logo

For the Inventor, By the Inventor

Kaohsiung, Taiwan

Cherng-Chyi Tzeng

This inventor holds 20 USPTO granted patents and 2 EPO patents. Top assignees: Kaohsiung Medical University, Chang Gung University, Chang Gung University of Science and Technology. Active years: 1997-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cherng-Chyi Tzeng. Retrieved from https://idiyas.com/inventor/cherng-chyi-tzeng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.2

ph-index = 4

Forward Citations = 48(Granted Patents)


Company Filing History:

goldMedal17 out of 147 
 
Kaohsiung Medical University
 patents
silverMedal1 out of 185 
 
Chang Gung University
 patents
bronzeMedal1 out of 8 
 
Chang Gung University of Science and Technology
 patents
4. 1 out of 544 
 
National Science Council
 patents
5. 1 out of 1 
 
National Science Council (Taiwan)
 patent
6. 1 out of 9 
 
Pharmaceutical Industry Technology and Development Center
 patents
where one patent can have more than one assignee

Years Active: 1997-2021

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 11135206 - Pyrazolo[4,3-c]quinoline derivatives for inhibition of β-glucuronidase (2021-10-05),
2. 11052072 - Pyrazolo[4,3-C] quinoline derivatives for inhibition of β-glucuronidase (2021-07-06),
3. 10654848 - Neutrophil inflammation inhibitor and uses thereof (2020-05-19),
4. 9415114 - Conformations of divergent peptides with mineral binding affinity (2016-08-16),
5. 9314533 - Conformations of divergent peptides with mineral binding affinity (2016-04-19),
6. 9314503 - Sustained release systems and preparation method thereof (2016-04-19),
7. 8952033 - 4-anilinofuro[2,3-b]quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same (2015-02-10),
8. 8889828 - Conformations of divergent peptides with mineral binding affinity (2014-11-18),
9. 8883862 - Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel (2014-11-11),
10. 8865220 - Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheres (2014-10-21),
11. 8663677 - Controlled release system and manufacturing method thereof (2014-03-04),
12. 8273760 - [object Object] (2012-09-25),
13. 8138184 - Isoxazole derivatives and pharmaceutical compositions comprising the same (2012-03-20),
14. 7829567 - Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same (2010-11-09),
15. 7763633 - [object Object] (2010-07-27),

Title: The Innovative Journey of Inventor Cherng-Chyi Tzeng

Introduction:

Cherng-Chyi Tzeng, a visionary inventor hailing from Kaohsiung, Taiwan, has left an indelible mark in the realm of technological advancements with his relentless pursuit of innovation.

Latest Patents:

With an impressive portfolio of 20 patents, Cherng-Chyi Tzeng's latest groundbreaking invention involves Pyrazolo[4,3-c]quinoline derivatives that exhibit specific inhibition activity to microbiota β-glucuronidase. These compounds show promise in preventing chemotherapy-induced diarrhea in cancer patients and can potentially enhance chemotherapeutic efficiency.

Career Highlights:

Having contributed significantly to the field of biomedical research, Cherng-Chyi Tzeng has worked with esteemed institutions such as Kaohsiung Medical University and the National Science Council. His innovative approaches have opened new avenues for improving healthcare outcomes and tackling complex medical challenges.

Collaborations:

Throughout his illustrious career, Cherng-Chyi Tzeng has collaborated with distinguished professionals in the field, including Yeh-Long Chen and Gwo-Jaw Wang. These fruitful partnerships have led to the development of cutting-edge solutions that have the potential to revolutionize the healthcare industry.

Conclusion:

Inventor Cherng-Chyi Tzeng's unwavering dedication to innovation and his passion for addressing critical healthcare issues have positioned him as a trailblazer in the world of inventors. His groundbreaking work not only demonstrates his scientific prowess but also underscores his commitment to creating meaningful impact through technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…